HOPE PACK: Open Payments
NPI 1043812142 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,209 in 15 payments from 9 companies in 2025. Trend: 2023 $1,828 · 2024 $1,564 · 2025 $1,209
Food & beverage: $1,209
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 2 | $250 |
| Galderma Laboratories, L.P. | 5 | $177 |
| Botanix SB Inc | 1 | $145 |
| PFIZER INC. | 2 | $128 |
| UCB, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $122 |
| GENZYME CORPORATION | 1 | $92 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $85 |
| Amgen Inc. | 1 | $84 |
Products named: Opzelura, SOFDRA, NEMLUVIO, CIBINQO, Bimzelx, SKYRIZI, DUPIXENT, Winlevi.
Industry payments across AZ — which companies pay providers there.
